BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11358836)

  • 1. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.
    Heimann P; El Housni H; Ogur G; Weterman MA; Petty EM; Vassart G
    Cancer Res; 2001 May; 61(10):4130-5. PubMed ID: 11358836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
    Argani P; Lui MY; Couturier J; Bouvier R; Fournet JC; Ladanyi M
    Oncogene; 2003 Aug; 22(34):5374-8. PubMed ID: 12917640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
    Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
    Ishiguro M; Iwasaki H; Ohjimi Y; Kaneko Y
    Oncol Rep; 2004 Jun; 11(6):1169-75. PubMed ID: 15138551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar soft part sarcoma--reciprocal translocation between chromosome 17q25 and Xp11. Report of a case with metastases at presentation and review of the literature.
    Uppal S; Aviv H; Patterson F; Cohen S; Benevenia J; Aisner S; Hameed M
    Acta Orthop Belg; 2003 Apr; 69(2):182-7. PubMed ID: 12769020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes.
    Weterman MA; van Groningen JJ; den Hartog A; Geurts van Kessel A
    Oncogene; 2001 Mar; 20(12):1414-24. PubMed ID: 11313885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma.
    Clark J; Lu YJ; Sidhar SK; Parker C; Gill S; Smedley D; Hamoudi R; Linehan WM; Shipley J; Cooper CS
    Oncogene; 1997 Oct; 15(18):2233-9. PubMed ID: 9393982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.
    Weterman MA; van Groningen JJ; Tertoolen L; van Kessel AG
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13808-13. PubMed ID: 11717438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins.
    Weterman MJ; van Groningen JJ; Jansen A; van Kessel AG
    Oncogene; 2000 Jan; 19(1):69-74. PubMed ID: 10644981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration.
    Mathur M; Das S; Samuels HH
    Oncogene; 2003 Aug; 22(32):5031-44. PubMed ID: 12902986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation carcinomas of the kidney.
    Argani P; Ladanyi M
    Clin Lab Med; 2005 Jun; 25(2):363-78. PubMed ID: 15848741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.
    Kuroda N; Tamura M; Tanaka Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH
    Pathol Int; 2009 Jul; 59(7):486-91. PubMed ID: 19563413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
    Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
    Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype.
    Kato H; Kanematsu M; Yokoi S; Miwa K; Horie K; Deguchi T; Hirose Y
    J Magn Reson Imaging; 2011 Jan; 33(1):217-20. PubMed ID: 21182142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.
    Weterman MA; Wilbrink M; Geurts van Kessel A
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15294-8. PubMed ID: 8986805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
    Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
    Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene.
    Sidhar SK; Clark J; Gill S; Hamoudi R; Crew AJ; Gwilliam R; Ross M; Linehan WM; Birdsall S; Shipley J; Cooper CS
    Hum Mol Genet; 1996 Sep; 5(9):1333-8. PubMed ID: 8872474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.